CareDx Announces Second KOAR Analysis Published in the Journal of the American Society of Nephrology
CareDx announced the publication of a second analysis from the Kidney Allograft Outcomes AlloSure Registry in the Journal of the American Society of Nephrology. The study of 1,258 patients found that AlloSure Kidney elevations were linked to a 3.7-fold and 6.4-fold higher adjusted hazard of allograft loss in intermediate and high-risk states.
Key figures
- Centers
- 56
- Patients
- 1258
- Elevation rate
- 36%
- Hazard ratio high
- 6.4-fold
- Hazard ratio intermediate
- 3.7-fold
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.